logo
Dan Ives: China Tariff Truce Revitalizes Bull Case for Apple as Half of User Base Approaches Upgrade Cycle

Dan Ives: China Tariff Truce Revitalizes Bull Case for Apple as Half of User Base Approaches Upgrade Cycle

Yahoo22-05-2025

The company has a huge manufacturing base in the giant Asian nation.
It also has options to shift it elsewhere.
10 stocks we like better than Apple ›
Among the many tech companies that rely on Chinese manufacturing, none is better placed to benefit from the recent thaw in that country's tariff war with America than Apple (NASDAQ: AAPL). That, at least, is the view of closely followed tech industry analyst Dan Ives of Wedbush Securities.
In mid-May, the White House announced that it and China agreed to drastically reduce certain tariffs and pause others. Ives said in a subsequent interview with Bloomberg that this should lead to a "dream scenario" for the tech giant. Here's a look at why the analyst thinks Apple has such a monster opportunity, and whether the company can truly take advantage of it.
It's telling that Apple emphasizes that the iPhone is designed in California. This might be something of a head fake to obscure the fact that the smartphones aren't made there. Rather, in the most likely case, your latest iPhone was made in China; estimates place the ratio at eight or nine out of every 10 of these products being produced in the massive Asian country.
To put this in some perspective, Apple is hardly the only China-dependent large U.S. tech enterprise. Other notable techies getting many of their goods made there are sector mainstays Intel and Texas Instruments, to name two of many. Also China is a huge market for sales of their finished products.
Apple has a longer made-in-China history than many might realize. In those long-ago days before the iPhone came into being, Apple had been making its products in China in 2001. The lure of notably cheaper manufacturing was impossible to resist for the company, which was in the early stages of its vaunted Steve Jobs-led comeback around that time.
So any sanctions on Chinese manufacturing threaten to put a real hurt on its operations. After all, despite its efforts to crank services revenue higher, the great bulk of the company's top line still comes from device sales -- 72% of the total in the most recently reported quarter.
That's a high level of dependency, and I think investors worry about this. Even after Apple stock rallied when the pause was announced, its shares are still down more than 19% year to date in price -- comparing unfavorably with the 1% rise of the bellwether S&P 500 index.
They won't stay down at that level, Ives firmly believes. He's maintaining his outperform (i.e., buy) recommendation on Apple and his price target of $270 per share. That anticipates a rather chunky upside of more than 30%.
To him, the current stage of the tariff dispute provides the company with tantalizing options. One is to accelerate device-making in India, a more recent addition to its manufacturing base that came onstream in 2017.
This is a more expensive option by as much as 10%, according to recent reporting from Reuters, because of India's relatively high import duties on phone components. However it gives the company some leverage in its dealings with Beijing and can be a safety valve if the tariff war starts to heat up again.
If it doesn't, so much the better. Ives said that the company can easily maintain its "China-driven" manufacturing regime.
Either way, one of the stated goals of the Trump administration is to bring manufacturing back to the United States. In the analyst's view, that just isn't going to happen. The notably higher costs of making goods in this country would mean a price tag of $3,500 per iPhone.
So Apple's production strategy is not likely to stray from low-labor-cost countries. What's encouraging about this, according to Ives, is that it's stepping into a massive upgrade cycle. Over the next two to three years, he told Bloomberg, essentially half of Apple's installed base will buy the latest models. That should be quite the boon, as those models will remain inexpensive to make.
The market's reaction to the big tariff news was muted, perhaps suggesting that many investors expected a cooling of the dispute. These folks also might not be buying Ives's assertion that the upgrade cycle will involve 50% of Apple users. Many skip several generations of iPhones before moving up to the latest models, myself included.
Still, I'd share the analyst's bullish view on the stock anyway, and I'm planning on holding on to my shares. For me, the great opportunity just now is not with phones, or even those slick recent iPad models or ultra-high-fidelity Beats headphones. Rather, it's the services offerings.
In the six months ending on March 29, Apple's revenue for such offerings climbed by 13% over the same period the previous year. Meanwhile, products revenue rose only 2%. I think this dynamic will continue, as the company can go in various directions with services to either widen existing revenue streams, such as from financing activities, or create new ones.
All that considered, I'd be in the Apple bullpen with Ives. I'm not totally sold on all of his analysis of the company's latest opportunities, but regardless I'd fully agree the stock is a buy.
Before you buy stock in Apple, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $642,582!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $829,879!*
Now, it's worth noting Stock Advisor's total average return is 975% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of May 19, 2025
Eric Volkman has positions in Apple. The Motley Fool has positions in and recommends Apple, Intel, and Texas Instruments. The Motley Fool recommends the following options: short May 2025 $30 calls on Intel. The Motley Fool has a disclosure policy.
Dan Ives: China Tariff Truce Revitalizes Bull Case for Apple as Half of User Base Approaches Upgrade Cycle was originally published by The Motley Fool

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results

Yahoo

time28 minutes ago

  • Yahoo

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results

Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc. (NASDAQ:MTSR) reported encouraging Phase 1 results for MET-233i, its once-monthly amylin analog, which showed a mean weight loss of up to 8.4% at Day 36 after subtracting the placebo. A laboratory technician researching a sample of cells in a biotechnology laboratory. The candidate supported monthly dosing with the longest half-life of any known amylin analog, 19 days. MET-233i had no safety indications and was well tolerated. The trial included 80 overweight or obese participants, with individual cases resulting in weight loss of up to 10.2%. MET-233i displayed high tolerability and dose-linear pharmacokinetics when tested in both single and multiple ascending dose formats. The majority of adverse gastrointestinal events occurred in the first week and were mild and dose-dependent. According to preliminary findings, it might make it practical to use its fully-biased GLP-1 RA candidate, MET-097i, in the first monthly GLP-1 + amylin combination therapy. Topline results from combination trials and an ongoing monotherapy study with MET-097i are anticipated in late 2025. Metsera, Inc. (NASDAQ:MTSR)'s HALO™ peptide stabilization platform supports the program. Metsera, Inc. (NASDAQ:MTSR) is a clinical-stage biopharmaceutical business focused on developing new treatments for obesity and metabolic diseases. It is one of the stocks with the biggest upside. While we acknowledge the potential of MTSR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Gold Advances on Middle East Tensions and Trump's Tariff Pledge
Gold Advances on Middle East Tensions and Trump's Tariff Pledge

Yahoo

time33 minutes ago

  • Yahoo

Gold Advances on Middle East Tensions and Trump's Tariff Pledge

(Bloomberg) -- Gold gained for a second day on increased tensions in the Middle East, with its haven status also supported by President Donald Trump's comments that he will inform trading partners on tariff rates within two weeks. Shuttered NY College Has Alumni Fighting Over Its Future Trump's Military Parade Has Washington Bracing for Tanks and Weaponry NYC Renters Brace for Price Hikes After Broker-Fee Ban NY Long Island Rail Service Resumes After Grand Central Fire NYC Mayoral Candidates All Agree on Building More Housing. But Where? Bullion rose as much as 0.6% to around $3,373 an ounce, extending a 1% gain from the earlier session when it was also boosted by a declining dollar. Buying interest increased after the US ordered some embassy staff to depart Baghdad and allowed military families to leave the Middle East, after Iran threatened to attack US bases if talks over its nuclear program fell through. Separately, Trump said he intended to send letters to trading partners in the next one to two weeks setting unilateral tariff rates, ahead of a July 9 deadline to reimpose higher duties on dozens of economies. The president also said a trade framework with China has been completed, with levies between the two largest economies to be maintained at their current levels. Uncertainties over global trade tensions and heightened geopolitical risks have rattled markets this year, boosting gold's allure as a store of value in turbulent times and powering a year-to-date advance of 28%. The precious metal, which reached an all-time high in April, has also been supported by increased central-bank buying. Spot gold was up 0.3% to $3,364.43 as of 7:59 a.m. Singapore time. The Bloomberg Dollar Spot Index was steady after falling 0.4% on Wednesday. Silver, platinum and palladium all gained. New Grads Join Worst Entry-Level Job Market in Years The Spying Scandal Rocking the World of HR Software American Mid: Hampton Inn's Good-Enough Formula for World Domination The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again ©2025 Bloomberg L.P.

China Gets First Private Builder Dollar Bond Offering in Years
China Gets First Private Builder Dollar Bond Offering in Years

Bloomberg

time37 minutes ago

  • Bloomberg

China Gets First Private Builder Dollar Bond Offering in Years

Seazen Group Ltd., one of the few major private-sector Chinese developers yet to default, started marketing a dollar bond that would be the first of its kind in more than two years. Once ranked among China's top 10 developers by contracted sales, the company set the initial price target for the three-year notes in the 13.25% yield to put area, a person familiar with the matter said. If successfully priced, it would be the first privately owned local builder to tap the publicly syndicated US-currency bond market since early 2023. The securities can be called and put after two years.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store